<scp>MHCI</scp> trafficking signal‐based <scp>mRNA</scp> vaccines strengthening immune protection against <scp>RNA</scp> viruses

The major histocompatibility complex class I (MHCI) trafficking signal (MITD) plays a pivotal role in enhancing the efficacy of mRNA vaccines. However, there was a lack of research investigating its efficacy in enhancing immune responses to RNA virus infections. Here, we have developed an innovative strategy for the formulation of mRNA vaccines. This approach involved the integration of MITD into the mRNA sequence encoding the virus antigen. Mechanistically, MITD-based mRNA vaccines can strengthen immune protection by mimicking the dynamic trafficking properties of MHCI molecule and thus expand the memory specific B and T cells. The model MITD-based mRNA vaccines encoding binding receptor-binding domain (RBD) of SARS-CoV-2 were indeed found to achieve protective duration, optimal storage stability, broad efficacy, and high safety.

Authors

Institutions

Publication Details

Journal
Bioengineering & Translational Medicine
Published
2024-08-15
DOI
https://doi.org/10.1002/btm2.10709
Citations
2
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
0.47

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MHCI trafficking signal‐based mRNA vaccines strengthening immune protection against RNA viruses

Songhui Zhai, Zhongwei Zhang, Hai Huang, Kepan Chen et al.
2 citations
Bioengineering & Translational Medicine
RNA Interference and Gene Delivery
0.47
article

MHCI trafficking signal‐based mRNA vaccines strengthening immune protection against RNA viruses

Songhui Zhai, Zhongwei Zhang, Hai Huang, Kepan Chen, Xin Jiang, Xingchen Peng, Yupei Zhang, Shugang Qin, Yaoyao Luo, Yuting Chen, Guo-Hong Li, Hao Li, Xi He, Xiangrong Song, Meiwan Chen, Zhiying Huang, Xing Lan
article en
2 citations

Abstract

The major histocompatibility complex class I (MHCI) trafficking signal (MITD) plays a pivotal role in enhancing the efficacy of mRNA vaccines. However, there was a lack of research investigating its efficacy in enhancing immune responses to RNA virus infections. Here, we have developed an innovative strategy for the formulation of mRNA vaccines. This approach involved the integration of MITD into the mRNA sequence encoding the virus antigen. Mechanistically, MITD-based mRNA vaccines can strengthen immune protection by mimicking the dynamic trafficking properties of MHCI molecule and thus expand the memory specific B and T cells. The model MITD-based mRNA vaccines encoding binding receptor-binding domain (RBD) of SARS-CoV-2 were indeed found to achieve protective duration, optimal storage stability, broad efficacy, and high safety.

Bioengineering & Translational MedicineVol. 10(1)
University of Macau (MO), Sichuan University (CN), West China Second University Hospital of Sichuan University (CN)
National Natural Science Foundation of China, China Postdoctoral Science Foundation, Sichuan University, National Key Research and Development Program of China, West China Hospital, Sichuan University
Openalex Percentile: Top 36%
RNA Interference and Gene Delivery
0.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.